Skip to main content

Table 6 Regression analysis models of risk factors associated with infection-related death among 76 patients infected by CRE, excluding urinary tract infections, between March 2011 and December 2012

From: A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome

Variable

Total

Survivors

Deaths

OR (95 % CI)

P

First model

 60 y or over

32 (42.1 %)

15 (34.0 %)

17 (53.1 %)

3.10 (0.81–11.87)

0.09

 Shock

47 (61.8 %)

18 (38.3 %)

29 (61.7 %)

5.84 (1.30–26.12)

0.02

 Dialysis

35 (46.0 %)

29 (61.7 %)

29 (61.7 %)

4.76 (1.22–18.55)

0.02

 Sensitive ATM less than 12 h

25 (32.9 %)

11 (44.0 %)

14 (56.0 %)

1.51 (0.45–5.01)

0.49

 Pneumonia

52 (68.4 %)

25 (48.0 %)

27 (56.0 %)

1.55 (0.40–6.03)

0.52

 Monotherapy

1 (1.3 %)

1 (100 %)

0 (0 %)

0.0001 (0.00–0.00)

0.97

 More than two comorbidities

   

1.50 (0.44–5.08)

0.50

  1. CRE carbapenem-resistant infection, OR odds ratio, CI confidence interval, ATM antimicrobial